Dietrich A. Stephan - Feb 13, 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Dietrich Stephan
Stock symbol
NBSE
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
4
Date filed
2/15/2023, 06:30 PM
Previous filing
Sep 30, 2022
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock Options Exercise $0 +655K +80.19% $0.00 1.47M Feb 13, 2023 Direct F1
holding NBSE Common Stock 1.27M Feb 13, 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Stock option (right to buy) Options Exercise $0 -655K -26% $0.00 1.86M Feb 13, 2023 Common Stock 655K $0.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the reporting person as a tenant by the entirety with his spouse.
F2 These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.